Skip to main content

ADVERTISEMENT

Zilver PTX

Original Contribution
09/30/2018

Haekyung Jeon-Slaughter, PhD1,2;  Houman Khalili, MD1,2;  Shirling Tsai, MD1,2;  Ehrin J. Armstrong, MD3;  Nicolas W. Shammas, MD4;  Omar Jawaid, MD3;  Hua Lu, MD1,2;  Tayo Addo, MD1;  Osvaldo Gigliotti, MD5;  Mazen Abu-Fadel, MD6;  Subhash Banerjee, MD1,2

Haekyung Jeon-Slaughter, PhD1,2;  Hou...
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically...
09/30/2018
Journal of Invasive Cardiology